{"id":2929,"date":"2023-04-26T13:52:00","date_gmt":"2023-04-26T11:52:00","guid":{"rendered":"https:\/\/p664637.webspaceconfig.de\/izb-biotech-news\/eisbach-starts-clinical-phase-1-trial-with-covid-19-antiviral-drug\/"},"modified":"2026-07-16T13:04:43","modified_gmt":"2026-07-16T11:04:43","slug":"eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb","status":"publish","type":"izb-biotech-news","link":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/","title":{"rendered":"Eisbach starts phase I clinical trial with COVID-19 antiviral"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2.<\/p>\n","protected":false},"featured_media":1146,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[80,81],"tags":[],"class_list":["post-2929","izb-biotech-news","type-izb-biotech-news","status-publish","format-standard","has-post-thumbnail","hentry","category-izb-news-en","category-izb-biotech-news-en"],"acf":[],"acf_migration":{"izb_related_company":"478"},"wpml_migration":{"language_code":"en","source_language_code":"de","trid":"11091"},"yoast_migration":{"_yoast_wpseo_metadesc":"The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2."},"permalink_migration":{"custom_uri":"izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eisbach starts phase I clinical trial with COVID-19 antiviral - IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.<\/title>\n<meta name=\"description\" content=\"The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eisbach starts phase I clinical trial with COVID-19 antiviral - IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\" \/>\n<meta property=\"og:description\" content=\"The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/\" \/>\n<meta property=\"og:site_name\" content=\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-16T11:04:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2024\/09\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1098\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\",\"name\":\"Eisbach starts phase I clinical trial with COVID-19 antiviral - IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp\",\"datePublished\":\"2023-04-26T11:52:00+00:00\",\"dateModified\":\"2026-07-16T11:04:43+00:00\",\"description\":\"The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp\",\"contentUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp\",\"width\":2000,\"height\":1098},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Eisbach starts phase I clinical trial with COVID-19 antiviral\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\",\"name\":\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\",\"description\":\"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eisbach starts phase I clinical trial with COVID-19 antiviral - IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","description":"The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/","og_locale":"en_US","og_type":"article","og_title":"Eisbach starts phase I clinical trial with COVID-19 antiviral - IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","og_description":"The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2.","og_url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/","og_site_name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","article_modified_time":"2026-07-16T11:04:43+00:00","og_image":[{"width":2000,"height":1098,"url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2024\/09\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/","url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/","name":"Eisbach starts phase I clinical trial with COVID-19 antiviral - IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","isPartOf":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage"},"image":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage"},"thumbnailUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2024\/09\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp","datePublished":"2023-04-26T11:52:00+00:00","dateModified":"2026-07-16T11:04:43+00:00","description":"The first human trial is investigating EIS-10700, an active substance that targets the RNA helicase of SARS-CoV-2.","breadcrumb":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage","url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2024\/09\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp","contentUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2024\/09\/Dr.-Adrian-Schomburg-CEO-Eisbach-Bio-GmbH-2000x1098-1.webp","width":2000,"height":1098},{"@type":"BreadcrumbList","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/eisbach-starts-phase-i-clinical-trial-with-covid-19-antiviral-innovations-und-gruenderzentrum-biotechnologie-izb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/p664637.webspaceconfig.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/p664637.webspaceconfig.de\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"Eisbach starts phase I clinical trial with COVID-19 antiviral"}]},{"@type":"WebSite","@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website","url":"https:\/\/p664637.webspaceconfig.de\/en\/","name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","description":"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/p664637.webspaceconfig.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/2929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news"}],"about":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/types\/izb-biotech-news"}],"version-history":[{"count":1,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/2929\/revisions"}],"predecessor-version":[{"id":2930,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/2929\/revisions\/2930"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media\/1146"}],"wp:attachment":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media?parent=2929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/categories?post=2929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/tags?post=2929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}